Impact of Intensive Atorvastatin Treatment on Levels of Scr, Hscrp and NGAL in Patients with Coronary Heart Disease Complicated Hyperuricemia after PCI

WANG Fang,BAI Xiu-ping,YANG Sheng-li
DOI: https://doi.org/10.3969/j.issn.1008-0074.2012.03.32
2012-01-01
Abstract:Objective:To observe impact of large dose atorvastatin on levels of serum creatinine(Scr),high sensitive C reactive protein(hsCRP) and neutrophil gelatinase associated lipocalin(NGAL) in patients with coronary heart disease(CHD) complicated hyperuricemia(HUA) after percutaneous coronary intervention(PCI) and explore protective effect of atorvastatin on kidney.Methods:A total of 60 CHD patients with HUA undergoing selective PCI were randomly divided into intensive treatment group(n=31,atorvastatin 40 mg/ d in peroperative period) and routine treatment group(n=29).Serum levels of Scr,hsCRP and NGAL were measured before,24h and 72h after PCI in two groups.Results:Scr level increased after PCI 24h and decreased after PCI 72h in two groups and there were no significant difference(P0.05);there were significant increase in levels of hsCRP and NGAL after PCI 24h,and those of intensive treatment group were significantly lower than those of routine treatment group [hsCRP(6.8±2.1)mg/ Lvs.(8.4±3.8)mg/ L,NGAL(57.1±12.7)ng/ ml vs.(66.2±17.9)ng/ ml],P0.05 all;levels of hsCRP and NGAL decreased after PCI 72h,compared with routine treatment group,there were significant decrease in hsCRP [(6.6±2.4) mg/ L vs.(5.5±1.5) mg/ L],and NGAL [(52.1±12.9) ng/ ml vs.(45.6±9.7) ng/ ml] in intensive treatment group(P0.05 both).Conclusion:Large dose atorvastatin within short term can decrease elevatory extent of serum levels of high sensitive C reactive protein and neutrophil gelatinase associated lipocalin in patients with coronary heart disease complicated hyperuricemia after percutaneous coronary intervention,thereby protect kidney.
What problem does this paper attempt to address?